CVS HEALTH CORPORATION Gain (Loss) Related to Litigation Settlement
CVS HEALTH CORPORATION (CVS) reported Gain (Loss) Related to Litigation Settlement of -$320.00 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-10-29.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2026-08-05
- CVS HEALTH CORPORATION gain (loss) related to litigation settlement for the quarter ending 2025-09-30 was -$320.00M.
- CVS HEALTH CORPORATION gain (loss) related to litigation settlement for the quarter ending 2025-06-30 was -$833.00M.
- CVS HEALTH CORPORATION gain (loss) related to litigation settlement for the quarter ending 2025-03-31 was -$387.00M.
- CVS HEALTH CORPORATION gain (loss) related to litigation settlement for the quarter ending 2024-12-31 was $0.00.
- CVS HEALTH CORPORATION gain (loss) related to litigation settlement for fiscal 2024 was -$100.00M.
- CVS HEALTH CORPORATION gain (loss) related to litigation settlement for fiscal 2023 was $0.00.
- CVS HEALTH CORPORATION gain (loss) related to litigation settlement for fiscal 2022 was -$5.80B.
- CVS HEALTH CORPORATION gain (loss) related to litigation settlement for fiscal 2021 was $0.00.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$320.00M 10-Q · filed 2025-10-29 | -$1.15B derived: sum of 2 quarters · filed 2026-08-05 | -$1.54B derived: sum of 3 quarters · filed 2026-08-05 | -$1.54B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$833.00M 10-Q · filed 2026-08-05 | -$1.22B 10-Q · filed 2026-08-05 | -$1.22B derived: sum of 3 quarters · filed 2026-08-05 | -$1.22B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$387.00M 10-Q · filed 2026-05-06 | -$387.00M derived: sum of 2 quarters · filed 2026-05-06 | -$387.00M derived: sum of 3 quarters · filed 2026-05-06 | -$387.00M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $0.00 derived: sum of 2 quarters · filed 2026-02-10 | $0.00 derived: sum of 3 quarters · filed 2026-02-10 | -$100.00M 10-K · filed 2026-02-10 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | -$100.00M 10-Q · filed 2025-10-29 | -$100.00M derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 | -$100.00M 10-Q · filed 2025-07-31 | -$100.00M derived: sum of 3 quarters · filed 2025-05-01 | -$100.00M derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-03-31 | -$100.00M 10-Q · filed 2025-05-01 | -$100.00M derived: sum of 2 quarters · filed 2025-05-01 | -$100.00M derived: sum of 3 quarters · filed 2025-05-01 | -$100.00M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $0.00 derived: sum of 2 quarters · filed 2025-02-12 | $0.00 derived: sum of 3 quarters · filed 2025-02-12 | $0.00 10-K · filed 2025-02-12 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | -$99.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | -$99.00M derived: sum of 3 quarters · filed 2025-02-12 | -$5.32B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-01 | -$99.00M derived: sum of 2 quarters · filed 2025-02-12 | -$5.32B derived: sum of 3 quarters · filed 2025-02-12 | -$5.32B derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -$99.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$5.32B derived: sum of 2 quarters · filed 2025-02-12 | -$5.32B derived: sum of 3 quarters · filed 2025-02-12 | -$5.80B 10-K · filed 2025-02-12 |
| 2022-09-30 | -$5.22B 10-Q · filed 2023-11-01 | -$5.22B derived: sum of 2 quarters · filed 2023-11-01 | -$5.70B 10-Q · filed 2023-11-01 | -$5.70B derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-02 | -$484.00M 10-Q · filed 2023-08-02 | -$484.00M derived: sum of 3 quarters · filed 2024-02-07 | -$484.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | -$484.00M 10-Q · filed 2023-05-03 | -$484.00M derived: sum of 2 quarters · filed 2024-02-07 | -$484.00M derived: sum of 3 quarters · filed 2024-02-07 | -$484.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $0.00 derived: sum of 2 quarters · filed 2024-02-07 | $0.00 derived: sum of 3 quarters · filed 2024-02-07 | $0.00 10-K · filed 2024-02-07 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-03 | $0.00 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $0.00 8-K · filed 2023-05-25 | |||
| 2013-12-31 | $72.00M 10-K · filed 2016-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |